RETRACTION: Long Noncoding RNA UFC1 is Activated by E2F1 and Exerts Oncogenic Properties by Functioning as a CeRNA of FOXP3.

J. Xi, J. Feng, S. Zeng, and P. Huang, "Long Noncoding RNA UFC1 is Activated by E2F1 and Exerts Oncogenic Properties by Functioning as a CeRNA of FOXP3," Cancer Medicine 7, no. 7 (2018): 3301-3310. https://doi.org/10.1002/cam4.1556. The above article, published online on 23 May 2018 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Stephen Tait; and John Wiley and Sons Ltd. The retraction has been agreed following an investigation into concerns raised by a third party, which revealed inappropriate duplications of image panels (Figure 3A-C, Figure 4C (HeLa-FOXP3 and GAPDH lanes) and D (FOXP3 lane)) between this and another article previously published by a different group of authors, in a different scientific context, elsewhere. Given the extent of the identified issues, the editors have lost confidence in the data presented and the article's conclusions can no longer be considered reliable. The authors have been informed of the allegations and the decision to retract but they remained unresponsive.

《Cancer Medicine》

Retraction.

《Cancer Medicine》

RETRACTION: Selection for TRAIL Resistance Results in Melanoma Cells with High Proliferative Potential.

J. J. Wu, X. D. Zhang, S. Gillespie, and P. Hersey, "Selection for TRAIL Resistance Results in Melanoma Cells with High Proliferative Potential," FEBS Letters 579, no. 9 (2005): 1940-1944, https://doi.org/10.1016/j.febslet.2005.02.041. The above article, published online on February 25, 2005, in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Michael Brunner; FEBS Press; and John Wiley and Sons Ltd. The retraction has been agreed upon following an investigation into concerns raised by a third party, which revealed inappropriate duplications of image sections within the article (Fig. 2A, 3A-C, 4A-B) depicting different experimental conditions. The authors were unable to provide a satisfactory explanation and due to the elapsed time the raw data was not available. Given the extent of the identified issues, the editors have lost confidence in the data presented and the article's conclusions can no longer be considered reliable.

《-》

RETRACTION: The Novel Role of Circular RNA ST3GAL6 on Blocking Gastric Cancer Malignant Behaviours Through Autophagy Regulated by the FOXP2/MET/Mtor Axis.

《Clinical and Translational Medicine》

RETRACTION: Combination of Aloin and Metformin Enhances the Antitumor Effect by Inhibiting the Growth and Invasion and Inducing Apoptosis and Autophagy in Hepatocellular Carcinoma Through PI3K/AKT/mTOR Pathway.

R. Sun, R. Zhai, C. Ma, and W. Miao, "Combination of Aloin and Metformin Enhances the Antitumor Effect by Inhibiting the Growth and Invasion and Inducing Apoptosis and Autophagy in Hepatocellular Carcinoma Through PI3K/AKT/mTOR Pathway," Cancer Medicine 9, no. 3 (2020): 1141-1151, https://doi.org/10.1002/cam4.2723. The above article, published online on 12 December 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors; the journal Editor-in-Chief, Stephen Tait; and John Wiley and Sons Ltd. The authors asked to retract the article as they found significant errors in the data collection and analysis, therefore the conclusions of the paper are not supported. Subsequently, an investigation into concerns raised by a third party revealed inappropriate duplication of images (Figure 1C, 2B and 4C, D) between this and other articles that were previously published or published shortly after in a different scientific context. Thus, the editors consider the conclusions of this manuscript substantially compromised. Although the authors initially asked for the retraction, when asked to approve the retraction wording, they remained unresponsive.

《Cancer Medicine》